Archive for October 22nd, 2019
Cystic fibrosis therapy…
Cystic fibrosis patients over 12 years of age who have a particular genetic mutation now have a newly approved drug treatment. This could offer hope for the 90% of patients who share this mutation, which means about 27,000 patients. The drug combination appears to be more effective when used together than when used separately. The CF diagnosis isn’t an automatic death sentence, but sufferers tend to acquire digestive problems, diabetes, and other life-shortening diseases and symptoms so they seldom reach age 50.